S H Kelkar Company Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 26, 2026

Key Highlights

The Latest Trading Price of S H Kelkar & Company Ltd is ₹ 127 as of 25 Mar 15:30 . The P/E Ratio of S H Kelkar & Company Ltd changed from 10.9 on March 2021 to 33.6 on March 2025 . This represents a CAGR of 25.25% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of S H Kelkar & Company Ltd changed from ₹ 1579 crore on March 2021 to ₹ 2460 crore on March 2025 . This represents a CAGR of 9.27% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of S H Kelkar & Company Ltd for the Dec '25 is ₹ 617.99 crore as compare to the Sep '25 revenue of ₹ 554.95 crore. This represent the growth of 11.36% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of S H Kelkar & Company Ltd for the Dec '25 is ₹ 89.53 crore as compare to the Sep '25 ebitda of ₹ 53.45 crore. This represent the growth of 67.5% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of S H Kelkar & Company Ltd changed from ₹ -86.82 crore to ₹ 32.63 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The Dividend Payout of S H Kelkar & Company Ltd changed from 31.03 % on March 2021 to -102 % on March 2025 . This represents a CAGR of NaN% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .

About S H Kelkar & Company Ltd

S H Kelkar & Company Limited was incorporated on July 1, 1955 in Mumbai.
After incorporation, the Company took over businesses carried on by Mr. V.G. Vaze as a sole proprietor of M/s S.H. Kelkar & Co and in partnership by the Firm 'M/s Saraswati Chemical Works'. The Company is engaged into manufacture, supply and exports of fragrances and aroma ingredients used in the food, beverage, personal care or household product industries.
The Company has a diverse and large client base including leading national and multinational FMCG companies, blenders of fragrances & flavours and fragrance & flavour producers. The Company operate 2 business segments, fragrance and flavours segment and also has global ingredients business segment.
The Company's strength is its capability to provide innovative and customised products created by the proficient team of specialised perfumers at the creative development centres in India, Singapore and Europe.

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

FAQs for the comparison of S H Kelkar & Company Ltd and Tatva Chintan Pharma Chem Ltd

Which company has a larger market capitalization, S H Kelkar & Company Ltd or Tatva Chintan Pharma Chem Ltd?

Market cap of S H Kelkar & Company Ltd is 1,757 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,717 Cr

What are the key factors driving the stock performance of S H Kelkar & Company Ltd and Tatva Chintan Pharma Chem Ltd?

The stock performance of S H Kelkar & Company Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for S H Kelkar & Company Ltd and Tatva Chintan Pharma Chem Ltd?

As of March 26, 2026, the S H Kelkar & Company Ltd stock price is INR ₹127.0. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1161.65.

How do dividend payouts of S H Kelkar & Company Ltd and Tatva Chintan Pharma Chem Ltd compare?

To compare the dividend payouts of S H Kelkar & Company Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.